Page last updated: 2024-08-18

framycetin and Burkitt Lymphoma

framycetin has been researched along with Burkitt Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, F; Ehlin-Henriksson, B; Kiss, C; Klein, E; Klein, G; Maeda, A; Nagy, N; Szekely, L; Takada, K	1

Other Studies

1 other study(ies) available for framycetin and Burkitt Lymphoma

Article	Year
EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain. International journal of cancer, 2001, Sep-01, Volume: 93, Issue:5 Topics: Anti-Bacterial Agents; Burkitt Lymphoma; Cell Line, Transformed; Cell Transformation, Viral; Drug Resistance, Microbial; Epstein-Barr Virus Nuclear Antigens; Flow Cytometry; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Neomycin; Promoter Regions, Genetic; Tumor Cells, Cultured; Viral Matrix Proteins; Viral Proteins	2001

Article

Year

EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain.

International journal of cancer, 2001, Sep-01, Volume: 93, Issue:5

Topics: Anti-Bacterial Agents; Burkitt Lymphoma; Cell Line, Transformed; Cell Transformation, Viral; Drug Resistance, Microbial; Epstein-Barr Virus Nuclear Antigens; Flow Cytometry; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Neomycin; Promoter Regions, Genetic; Tumor Cells, Cultured; Viral Matrix Proteins; Viral Proteins

2001